CHRS vs SBUX · rev $26.6M vs P/E 76, rev $37.18B
Coherus BioSciences Inc (CHRS) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian R. Niccol.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
CHRS currently screens at market cap $223.7M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the CHRS and SBUX stock pages for the full models.
Not investment advice.